NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alex P. HamiltonDirector2024-06-26108,426$0.32
$34.70kSell
Alex P. HamiltonDirector2024-06-2516,574$0.31
$5.14kSell

1 of 1

MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jacob D. Cohen364.97%9,075,000$24.32MInsider
Jonathan Arango40.22%1,000,000$2.68MInsider
Ackerman Capital Advisors LLC35.12%873,356$2.34MInstitution
Lorraine Pamela Dalessio7.04%175,000$469.00kInsider
Amanda Elizabeth Hammer7.04%175,000$469.00kInsider
Kenny Myers7.04%175,000$469.00kInsider
Geode Capital Management LLC5.28%131,327$351.96kInstitution
Peak6 Investments LLC3.55%88,258$236.53kInstitution
Mccollum Christoferson Group LLC3.45%85,800$229.94kInstitution
Alex P. Hamilton2.01%50,000$134.00kInsider

1 of 2

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX11.16%88.84%Net Selling
OTRK0.00%100.00%Net SellingNet Selling
HCTI0.23%99.77%
KDLY11.73%1.26%Net BuyingNet Buying
FOXO1.18%98.82%Net Selling

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 54.01% institutional shareholders, 429.85% Mangoceuticals insiders, and 0.00% retail investors. Jacob D. Cohen is the largest individual Mangoceuticals shareholder, owning 9.08M shares representing 364.97% of the company. Jacob D. Cohen's Mangoceuticals shares are currently valued at $23.69M.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.